WILLIAM J. PETERS - 08 Feb 2022 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
CFO, EVP & Treasurer
Signature
/s/ William J. Peters
Issuer symbol
AMPH
Transactions as of
08 Feb 2022
Transactions value $
-$120,000
Form type
4
Filing time
09 Feb 2022, 20:06:57 UTC
Previous filing
11 Jan 2022
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $149,500 +10,000 +9.4% $14.95 116,042 08 Feb 2022 Direct
transaction AMPH Common Stock Sale -$269,500 -10,000 -8.6% $26.95 106,042 08 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -10,000 -17% $0 48,074 08 Feb 2022 Common Stock 10,000 $14.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2021.
F2 Shares subject to the option are fully vested and immediately exercisable.